DE69600780T2 - 15-deoxyspergualin-analoge verbindungen, ihre verwendung als therapeutika und verfahren zu ihrer herstellung - Google Patents

15-deoxyspergualin-analoge verbindungen, ihre verwendung als therapeutika und verfahren zu ihrer herstellung

Info

Publication number
DE69600780T2
DE69600780T2 DE69600780T DE69600780T DE69600780T2 DE 69600780 T2 DE69600780 T2 DE 69600780T2 DE 69600780 T DE69600780 T DE 69600780T DE 69600780 T DE69600780 T DE 69600780T DE 69600780 T2 DE69600780 T2 DE 69600780T2
Authority
DE
Germany
Prior art keywords
pct
group
therapeutics
compounds
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69600780T
Other languages
English (en)
Other versions
DE69600780D1 (de
Inventor
Luc Lebreton
Patrice Renaut
Philippe Durand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratories Fournier SAS
Original Assignee
Fournier Industrie et Sante SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9501553A external-priority patent/FR2730488B1/fr
Priority claimed from FR9509884A external-priority patent/FR2737891B1/fr
Application filed by Fournier Industrie et Sante SAS filed Critical Fournier Industrie et Sante SAS
Application granted granted Critical
Publication of DE69600780D1 publication Critical patent/DE69600780D1/de
Publication of DE69600780T2 publication Critical patent/DE69600780T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24—Y being a hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00—Compounds containing azido groups
    • C07C247/02—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C247/12—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Transplantation (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69600780T 1995-02-10 1996-02-07 15-deoxyspergualin-analoge verbindungen, ihre verwendung als therapeutika und verfahren zu ihrer herstellung Expired - Fee Related DE69600780T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9501553A FR2730488B1 (fr) 1995-02-10 1995-02-10 Analogues de la 15-deoxyspergualine, leur utilisation en therapeutique et leur procede de preparation
FR9509884A FR2737891B1 (fr) 1995-08-17 1995-08-17 Analogues chiraux de la 15-deoxyspergualine, procede de preparation et utilisation en therapeutique
PCT/FR1996/000203 WO1996024579A1 (fr) 1995-02-10 1996-02-07 Analogues de la 15-deoxyspergualine, leur utilisation en therapeutique et leur procede de preparation

Publications (2)

Publication Number Publication Date
DE69600780D1 DE69600780D1 (de) 1998-11-19
DE69600780T2 true DE69600780T2 (de) 1999-05-27

Family

ID=26231751

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69600780T Expired - Fee Related DE69600780T2 (de) 1995-02-10 1996-02-07 15-deoxyspergualin-analoge verbindungen, ihre verwendung als therapeutika und verfahren zu ihrer herstellung

Country Status (9)

Country Link
US (1) US5883132A (de)
EP (1) EP0755380B1 (de)
JP (1) JPH09511765A (de)
AT (1) ATE172189T1 (de)
CA (1) CA2187281A1 (de)
DE (1) DE69600780T2 (de)
DK (1) DK0755380T3 (de)
ES (1) ES2125714T3 (de)
WO (1) WO1996024579A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2183917A1 (en) * 1995-09-26 1997-03-27 Xuebao Wang Preparation of optically active (s)-(-) and (r)-(+)- deoxyspergualin and novel intermediates thereof
DE19728436A1 (de) * 1997-07-03 1999-01-07 Niels Franke Niedrigdosierte 15-Desoxyspergualin-Präparate
EP2583678A3 (de) 2004-06-24 2013-11-13 Novartis Vaccines and Diagnostics, Inc. Immunstimulatoren kleiner Moleküle und Assays für deren Nachweis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5942356A (ja) * 1982-09-02 1984-03-08 Microbial Chem Res Found スパガリン関連化合物およびその製造法
US4525299A (en) * 1983-05-10 1985-06-25 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai (-)-15-Deoxyspergualin, process for the preparation thereof, and intermediate of the same
JPS61129119A (ja) * 1984-11-13 1986-06-17 Microbial Chem Res Found 新規免疫抑制剤
US5061787A (en) * 1988-06-24 1991-10-29 Nippon Kayaku Kabushiki Kaisha Novel spergualin-related compounds and compositions
FR2698628B1 (fr) * 1992-12-02 1995-02-17 Fournier Ind & Sante Analogues de 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique.

Also Published As

Publication number Publication date
EP0755380A1 (de) 1997-01-29
ATE172189T1 (de) 1998-10-15
CA2187281A1 (en) 1996-08-15
DK0755380T3 (da) 1999-06-23
EP0755380B1 (de) 1998-10-14
WO1996024579A1 (fr) 1996-08-15
ES2125714T3 (es) 1999-03-01
JPH09511765A (ja) 1997-11-25
US5883132A (en) 1999-03-16
DE69600780D1 (de) 1998-11-19

Similar Documents

Publication Publication Date Title
DE59510533D1 (de) Verwendung von dioxomorpholinen zur bekämpfung von endoparasiten, neue dioxomorpholine und verfahren zu ihrer herstellung
ATE225348T1 (de) Substituierte azaindolylidenderivate und verfahren zu ihrer herstellung
ATE166357T1 (de) Galakturonsäurederivate, verfahren zur ihrer herstellung und ihre verwendung
AT397654B (de) Neue pleuromutilinderivate, ihre verwendung und verfahren zu ihrer herstellung
DE59104905D1 (de) 99m-Tc-CYCLOPENTADIENYLCARBONYL -KOMPLEXE, VERFAHREN ZU IHRER HERSTELLUNG SOWIE IHRE VERWENDUNG IN DER DIAGNOSTIK.
DE3684445D1 (de) Neue harnstoffderivate, verfahren zu ihrer herstellung und herbizide.
DE69600780T2 (de) 15-deoxyspergualin-analoge verbindungen, ihre verwendung als therapeutika und verfahren zu ihrer herstellung
ATE140215T1 (de) 15-deoxyspergualin analoge verbindungen, verfahren zu ihrer herstellung und ihre verwendung als therapeutika zur unterdrückung der immunabwehr
DE69719511D1 (de) Antivirale 2,4-pyrimidindion-derivate und verfahren zu ihrer herstellung
DE69318711T2 (de) Desferrioxamine-b salze und ihre verwendung als oral wirksame eisen- chelatbildner
DE69029861T2 (de) N-acyl-substituierte azazyklische verbindungen, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE60017151D1 (de) Verfahren zur reinigung fluorierter hydroxylverbindungen
ATE139242T1 (de) Modifizierte huminate, verfahren zu ihrer herstellung und verwendung
DE69725167D1 (de) N-benzolsulfonyl-l-prolin derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
UA42798C2 (uk) Аналоги 15-дезоксиспергуаліну, спосіб їх одержання, проміжні сполуки, фармацевтична композиція на основі аналогів 15-дезоксипергуаліну
ATE104313T1 (de) Neue 9-g(a)-hydroxy-3-oxo-4,24(25)-stigmastadien26-s|urederivate,verfahren zur herstellung und heilmittel daraus.
DE69818051D1 (de) N-benzenesulfonyl-l-prolin-derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
DE69326767D1 (de) Verfahren und zwischenprodukte zur herstellung von bis-aza-bicyclischen anxiolytica
DE69412085T2 (de) Neues verfahren zur herstellung von beta-alkoxyacrylsäure
DE69025185T2 (de) Verbesserter prozess zur darstellung von keton-verbindungen
ATE175199T1 (de) Verfahren zur herstellung von 2-substituierten 5- chlorimidazol-4-carbaldehyden
DE59309487D1 (de) Isoxazolcarbonsäureamide, verfahren zu ihrer herstellung und ihre verwendung
ATE354575T1 (de) Spirobenzofuranlactam-derivate, verfahren zu ihrer herstellung und verwendung derselben
EA200000992A1 (ru) Производное барбитуровой кислоты и содержащий его профилактический и терапевтический агент для костной и хрящевой системы
ATE175956T1 (de) Verfahren zur herstellung von o-(2-hydroxyalkyl)- oximen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: LABORATOIRES FOURNIER S.A., DIJON, FR

8339 Ceased/non-payment of the annual fee